Document is current
Any future updates will be listed below
-
Authors
Lv, Lei
Yang, Jingjing
Liu, Qingyang
Li, YanFen
Xu, Lingmin
Li, Meng
Zhang, Ran
Huang, Sai
Jing, Yu
Dou, Liping
-
Funding
Funding for this research was provided by:
the National Key R&D Program of China (2023YFC2507800,2021YFA1100904)
the National Natural Science Foundation of China (Nos.82570261,82270162,82270224,82200169)
the Military medical support innovation and generate special program (21WQ034)
the Special Research Found for Health Protection (24BJZ30, 21BJZ30)
Beijing Nova Program cross-cutting Project (20230484407)
the Logistics Independent Research Program (2023hqzz09)
Capital’s Funds for Health Improvement and Research (2024-2-5063)
- License Information
-
More Information
Article History
Received: 6 January 2026
Accepted: 20 May 2026
First Online: 4 June 2026
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The Ethics Committee of the First Medical Center of the PLA General Hospital approved the studies involving humans. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation from participants or their legal guardians/next of kin was not required, as per national legislation and institutional requirements. Name of the Ethics Committee: The Ethics Committee of the Chinese PLA General Hospital. Name of the Ethics Committee: The Ethics Committee of the Chinese PLA General Hospital. Approval Number: S2022-240-01. Confirmation of Helsinki Declaration: State that the study was performed in accordance with the Declaration of Helsinki. This study was approved by the Ethics Committee of the Chinese PLA General Hospital (Approval No: S2022-240-01. All procedures were performed in accordance with the ethical standards of the institutional research committee and with the Helsinki Declaration and its later amendments.
